PATENT CLAIM ANALYSIS

Application Number: 15761804
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["536", "024500"]

Abstract:
The present invention relates to nucleic acids, compositions and methods for the treatment of diseases, in particular for the treatment of facioscapulohumeral dystrophy.

Claim (Index 8):
The vector according to  claim 7 , which is a viral vector coding said antisense oligonucleotide.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 90.0
- Lexical Diversity: 1.2381
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15549072', '15047258', '15295591', '14234413', '15078029']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6543920174848368
- 35 USC 102 Novelty (BERT): 0.5244152150685916
- Combined Prediction Score: 0.6413943372432123
- Mean Citation Score: 299.330526
- Max Citation Score: 351.25613
- Similarity Product: 273.7190700916576

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test